ELIQUIS 0.15 mg, granules in a capsule to be opened 28 capsules
Brand page: Eliquis (apixaban) — all forms and strengths in France
Active ingredients: Apixaban
Commercialized according to BDPMDispensing in France: Prescription only
Granules in capsules28 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELIQUIS 0,15 mg, granulés en gélule à ouvrir
- Pharmaceutical form
- granulés en gélule
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 28 gélule(s)
- Marketing authorisation holder
- BRISTOL-MYERS SQUIBB / PFIZER EEIG (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62111096CIP73030197CIP133400930301975Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APIXABANgranulés | 0,15 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.